SCHEMBL20723409

SCHEMBL20723409

Cc1ccc(-c2ccc([B-](c3ccc(-c4ccc(C)cc4)cc3)(c3ccc(-c4ccc(C)cc4)cc3)c3ccc(-c4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.47
TDP1 Q9NUW8 3/20 0.47
HPGD P15428 3/20 0.38
NPC1 O15118 2/20 0.38
NFKB1 P19838 2/20 0.38
RAB9A P51151 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ENPP3 O14638 1/20 0.37
ENPP1 P22413 1/20 0.37
KIF11 P52732 1/20 0.37
ALDH1A1 P00352 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473142 0.91 ACHE (0.57) ACHETDP1ALDH1A1CA1CA2
SCHEMBL15452890 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
SCHEMBL135348 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
Potassium Ion SCHEMBL133256 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
Ammonia Solution, Strong SCHEMBL26908485 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
SCHEMBL15452864 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
Lithium Ion SCHEMBL136304 0.88 ACHE (0.53) ACHETDP1HPGDALDH1A1CA1
Trimethylammonium SCHEMBL139184 0.82 ACHE (0.47) ACHETDP1ALDH1A1CA1CA2
Tetramethylammonium Ion SCHEMBL8571958 0.82 ACHE (0.47) ACHETDP1ALDH1A1CA1CA2
SCHEMBL3287696 0.80 ACHE (0.73) ACHETDP1HPGDENPP3ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12478677-B2 Tunable luminescent organic salts for enhanced imaging and photodynamic therapy BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2025-11-25 US claimed
US-20200230238-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2020-07-23 US claimed
EP-3664892-A2 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY Board of Trustees of Michigan State University (US) 2020-06-17 EP claimed
WO-2019032683-A2 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2019-02-14 WO claimed
US-20260144876-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2026-05-28 US disclosed
US-12478677-B2 Tunable luminescent organic salts for enhanced imaging and photodynamic therapy BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2025-11-25 US disclosed
WO-2024054299-A2 MULTIVALENT ORGANIC SALTS FOR PHOTOVOLTAICS BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2024-03-14 WO disclosed
US-20200230238-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2020-07-23 US disclosed
EP-3664892-A2 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY Board of Trustees of Michigan State University (US) 2020-06-17 EP disclosed
WO-2019032683-A2 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2019-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144876-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY SLC10A6, ACTB, SLC6A6 ACHE 2772/4885TDP1 2402/4885HPGD 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.